MVT: In the News

Search

Dec 22, 2020

Microvascular Therapeutics enters licensing agreement with UNC Chapel Hill and Columbia University

Microvascular Therapeutics (MVT) has entered into a licensing agreement with the University of North Carolina at Chapel Hill and Columbia...

Aug 1, 2020

Microvascular Therapeutics receives NIH SBIR Phase I funds for its Alzheimer program

Tucson, Arizona, August 1st, 2020: Microvascular Therapeutics (MVT), a biotechnology company based in Tucson, AZ, was recently awarded a...

Jul 21, 2020

Microvascular Therapeutics receives NIH SBIR Phase I funds for its program to treat heart attack

Tucson, Arizona, July 22nd, 2020: Microvascular Therapeutics (MVT), a biotechnology company based in Tucson, AZ, was recently awarded a...

Jul 10, 2018

Microvascular Therapeutics Licenses Patent from Triangle Biotechnology Inc.

Microvascular Therapeutics (MVT), LLC, a privately-held Tucson-based biotechnology company, has licensed a patent from Triangle...

Mar 30, 2018

MVT Receives $1.7M Grant from National Heart, Lung, and Blood Institute of Health

Microvascular Therapeutics (MVT), a Tucson based biotechnology company, announced that it has been awarded a $1.7M grant from the...

Nov 1, 2017

Patent: Phospholipid Composition and Microbubbles and Emulsions Formed Using Same

READ PATENT >